doxorubicin prodrug (ProQinase)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namedoxorubicin prodrug (ProQinase)
Drug Alias NamePSA-activated doxorubicin prodrug (Tumor Biology Center Freiburg)albumin-binding doxorubicin prodrug (ProQinase)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitorsVirus DNA polymerase inhibitors
TargetsVirus DNA polymeraseTopoisomerase II
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesReaction Biology Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesReaction Biology Corp
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A